We are pleased to advise Terry Clune as majority shareholder on the sale of Immedis to UKG Inc.

The team was led by Michael Coyle (Corporate and M&A) and included Tim Gleeson and Kate Fahy (Corporate and M&A), Ryan Ferry (Litigation, Dispute Resolution and Investigations), Ian Duffy, Aoife Mac Ardle and Alison Peate (Technology & Innovation), Olivia Mullooly (Intellectual Property), Michael Shovlin (Pensions and Employee Benefits), David Kilty (Tax), Patrick Horan, Simon Breen and Ailbhe Ó Faoláin (Competition & Regulated Markets) and Ciara McDermott (Employment).

Read more here.